The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

China Antifungal Drugs Market - Segmented By Product Type, Application and Dosage Form - Industry Analysis, Size, Share, Y-O-Y Growth Trends and Forecasts 2016-2021

China Antifungal Drugs Market - Segmented By Product Type, Application and Dosage Form - Industry Analysis, Size, Share, Y-O-Y Growth Trends and Forecasts 2016-2021

Publishing Date : Dec, 2016

License Type :
 

Report Code : 429441

No of Pages : 72

Synopsis
Antifungal drugs are used to cure fungal infections which are usually caused by unclean, unhygienic and damp environment. Fungal infections are the invasion of epithelial tissue by microscopic organisms. Systemic fungal infections are caused by the indigestion or inhalation of fungus spores and cause fungal pneumonia and opportunistic fungus causes diseases like candidaisis, meningitis, mucormycosis, etc. Most of the fungal infections and fungal diseases are generally non-lethal but they are very uncomfortable to live with. Commonly occurring fungal infections are responsible for the rise of antifungal drugs market. Antifungal drugs work through various mechanisms such as by inhibiting cell wall formation, cell membrane disruption and cell division.
The antifungal drugs market is segmented by drug type into Echinocandins, Azoles, Polyenes, Allylamines and Other Drugs. Polyenes are further classified into Amphotericin B, Nystatin and Natamycin. Based on the type of therapeutic indications it is segmented into Aspergillosis, Dermatophytosis, Candidiasis, Other therapeutic indications. Also, the market is segmented by applications into Powders, Ointments, Drugs, Pastes.
The major factors driving the market are increase in susceptible immune compromised patient population and rising incidences of fungal infections along with government and corporate investments to tackle the issues. However, there are some road blocks like increase of drug resistant strains, challenges in anti-fungal drug development and presence of generics. Nevertheless, the market has lucrative opportuntis in the form of Limited effective Therapeuti options, increasing disposable per-capita income if manufacturers can overcome challenges like growing resistance to anti-fungal drugs and usage of traditional alternatives.
The China Antifungal Drugs Market is estimated at $XX million in 2016 and is poised to be growing at a CAGR of XX%, to reach $XX million by 2021. XXXXXXXX is the largest segment where as XXXXXXX is showing a promising growth in the region in the given forecast period of 2016-2021.

Geographical Area
China
Index
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Anti-Fungals Classification
3.2 Epidemiology
3.2.1 Aspergillosis
3.2.2 Candida Species Infections
3.2.3 Dermatophytosis
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.1.1 Increase in susceptible immune compromised patient population
4.1.2 Increasing incidence of fungal infections
4.1.3 Increasing government and Corporate Funding
4.2 Market Restraints
4.2.1 Increasing drug resistance strains

4.2.2 Challenges in antifungal drug development
4.2.3 Presence of Generics and alternative therapies
4.3 Key Challenges
4.3.1 Limited Effective Therapeutic Options
4.3.2 Oppurtunities for New Drugs
4.3.3 Increasing Disposable income Percapita
4.4 Current Opportunities in the Market
4.4.1 Growing resistance to antifungal drugs
4.4.2 Use of traditional medicines to control fungus
5. Market Segmentation
5.1 Introduction
5.2 China Antifungal Drugs Market, By Product Type
5.2.1 Introduction
5.2.2 Azoles
5.2.2.1 Introduction
5.2.2.2 Flucanazoles
5.2.2.3 Itraconazoles
5.2.2.4 Clotrimazoles
5.2.2.5 Other Azoles
5.2.3 Allylamines
5.2.3.1 Introduction
5.2.3.2 Terbinafine
5.2.3.3 Naftifine
5.2.3.4 Other Allylamines
5.2.4 Echinocandins
5.2.4.1 Introduction
5.2.4.2 Capsofungin
5.2.4.3 Micafungin
5.2.4.4 Other Echinocandins
5.2.5 Ployenes
5.2.5.1 Introduction
5.2.5.2 Amphotericin B
5.2.5.3 Nystatin
5.2.5.4 Natamycin
5.2.6 Others
5.3 China Antifungal Drugs Market, By Dosage Form
5.3.1 Introduction
5.3.5 Solutions
5.3.5.1 Y-O-Y Growth Rate
5.3.5.2 Pricing
5.3.3 Tablets & Capsules
5.3.3.1 Y-O-Y Growth Rate
5.3.3.2 Pricing
5.3.4 Ointments & Creams
5.3.4.1 Y-O-Y Growth Rate
5.3.4.2 Pricing
5.3.5 Powders
5.3.5.1 Y-O-Y Growth Rate
5.3.5.2 Pricing
5.3.6 Others
5.4 China Antifungal Drugs Market, By Applications
5.4.1 Introduction
5.4.2 Aspergillosis
5.4.3 Candidiasis
5.4.4 Dermatophytosis
5.4.5 Other Fungal Diseases

Published By : Market Data Forecast

Why ‘The Market Reports’